Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases.

Romano S, D'Angelillo A, Romano A, Nappo G, Romano MF.

Curr Med Chem. 2014;21(14):1631-8. Review.

PMID:
23992331
2.

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

Darini CY, Pisani DF, Hofman P, Pedeutour F, Sudaka I, Chomienne C, Dani C, Ladoux A.

Oncogene. 2012 May 10;31(19):2438-49. doi: 10.1038/onc.2011.421. Epub 2011 Sep 19.

PMID:
21927026
3.

Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis.

Mueller MT, Hermann PC, Heeschen C.

Front Biosci (Elite Ed). 2010 Jan 1;2:602-13. Review.

PMID:
20036905
4.

Tumour-microenvironmental interactions: paths to progression and targets for treatment.

Box C, Rogers SJ, Mendiola M, Eccles SA.

Semin Cancer Biol. 2010 Jun;20(3):128-38. doi: 10.1016/j.semcancer.2010.06.004. Epub 2010 Jul 3. Review.

PMID:
20599506
5.

Host and tumour factors in cancer metastasis.

Fidler IJ.

Eur J Clin Invest. 1990 Oct;20(5):481-6. Review.

PMID:
2124977
6.

Experimental chemotherapy and concepts related to the cell cycle.

Tannock IF.

Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Feb;49(2):335-55. Review.

PMID:
3510996
7.

Concepts of metastasis in flux: the stromal progression model.

Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C, Rüegg C.

Semin Cancer Biol. 2012 Jun;22(3):174-86. doi: 10.1016/j.semcancer.2012.02.007. Epub 2012 Feb 21. Review.

8.

Invasion and metastasis.

Carr I, Orr FW.

Can Med Assoc J. 1983 May 15;128(10):1164-7.

9.

Host genetics and tumour metastasis.

Hunter KW.

Br J Cancer. 2004 Feb 23;90(4):752-5. Review.

10.

Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.

Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML.

Cancer Surv. 1988;7(4):597-629. Review.

PMID:
3072068
11.

HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.

Philip B, Ito K, Moreno-Sánchez R, Ralph SJ.

Carcinogenesis. 2013 Aug;34(8):1699-707. doi: 10.1093/carcin/bgt209. Epub 2013 Jun 5. Review.

PMID:
23740838
12.

Stem-cell origin of metastasis and heterogeneity in solid tumours.

Tu SM, Lin SH, Logothetis CJ.

Lancet Oncol. 2002 Aug;3(8):508-13. Review.

PMID:
12147437
13.

Role of the host stroma in cancer and its therapeutic significance.

Tarin D.

Cancer Metastasis Rev. 2013 Dec;32(3-4):553-66. doi: 10.1007/s10555-013-9438-4. Review.

PMID:
23625010
14.
15.

New insights into the mechanisms of organ-specific breast cancer metastasis.

Lorusso G, Rüegg C.

Semin Cancer Biol. 2012 Jun;22(3):226-33. doi: 10.1016/j.semcancer.2012.03.007. Epub 2012 Apr 5. Review.

PMID:
22504658
16.

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T.

Nat Rev Cancer. 2005 Sep;5(9):744-9. Review.

PMID:
16148886
17.

Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.

Paterlini-Bréchot P.

Future Oncol. 2011 Jul;7(7):849-71. doi: 10.2217/fon.11.32. Review.

PMID:
21732757
18.

Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model.

Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP.

BMC Cancer. 2009 Apr 28;9:128. doi: 10.1186/1471-2407-9-128.

19.

Cancer stem cells and metastasis.

Sampieri K, Fodde R.

Semin Cancer Biol. 2012 Jun;22(3):187-93. Review.

PMID:
22774232
20.

Metastatic cancer stem cells: new molecular targets for cancer therapy.

Leirós GJ, Balañá ME.

Curr Pharm Biotechnol. 2011 Nov;12(11):1909-22. Review.

PMID:
21470128

Supplemental Content

Support Center